Assistant Professor, Internal Medicine, Mayo Medical School

Hematology

Dr. Candido E. Rivera-Linares, MD

Candido Rivera Linares works in the field of Hematology. He went to University of Puerto Rico School of Medicine. Candido E. Rivera-Linares is also a published doctor. He has 15 publication published. The most recent publication is: Infection of human endothelial cells with Epstein-Barr virus.

Publications

Use of the Functional Assessment of Cancer Therapy-Anemia in Persons with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia.
Clinical Reasoning: A 69-year-old man with leukocytosis and hemorrhagic brain lesions.
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenstrom ma...
The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.
Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard-Soulier syndrome.
Infection of human endothelial cells with Epstein-Barr virus.
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transpla...
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients.
In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.

Doctors Specialties

Hematology

Accepted Insurances

Education

National Institutes of Health Clinical Center
Thomas Jefferson University
University of Puerto Rico School of Medicine

Hospital

Mayo Clinic - Jacksonville, Florida

Drug Facts

NPI NUMBER		1497744122
NPPES Provider LastName		RIVERA-LINARES
NPPES Provider FirstName		CANDIDO
NPPES Provider ZIPCode		322241865
NPPES Provider State		FL
Specialty Description		Hematology/Oncology
Total Claim Count		471.0
Distinct Opioid Count		4.0
Opioid Claim Count		63.0
Percent Opioid Claims		13.38

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1497744122
Last Name Of The Provider	RIVERA-LINARES
First Name Of The Provider	CANDIDO
View All

Similar Doctors

	Dr. Yuval Z. Naot, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Safeer A. Ashraf, MD This Doctor is OpenDoctor Recommended.
	Dr. Mehdi M. Moezi, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith M. Justice, MD This Doctor is OpenDoctor Recommended.
	Dr. Suprith Badarinath, MD This Doctor is OpenDoctor Recommended.
	Dr. Alvaro Moreno-Aspitia, MD This Doctor is OpenDoctor Recommended.
	Dr. Vivek Roy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kenneth H. Goldstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Gerardo Colon-Otero, MD This Doctor is OpenDoctor Recommended.
	Dr. Lawrence A. Solberg Jr., MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mark Steciuk, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. George P. Kim, MD
	Dr. Jennifer A. Crozier, MD This Doctor is OpenDoctor Recommended.
	Dr. Fauzia N. Rana, MD